Jeff Packman

2.5k total citations · 1 hit paper
12 papers, 1.3k citations indexed

About

Jeff Packman is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, Jeff Packman has authored 12 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Nephrology and 3 papers in Rheumatology. Recurrent topics in Jeff Packman's work include Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Parathyroid Disorders and Treatments (5 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jeff Packman is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Parathyroid Disorders and Treatments (5 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Jeff Packman collaborates with scholars based in United States, Portugal and Germany. Jeff Packman's co-authors include Donna R. Grogan, Jeffery W. Kelly, Richard Labaudinière, Ian A. Wilson, Stephen Connelly, Michael J. DeVit, Lan Wang, R. Luke Wiseman, Evan T. Powers and Christine Bulawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Bone and Mineral Research.

In The Last Decade

Jeff Packman

12 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

2012 572 citations Christine Bulawa, Stephen Connelly et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeff Packman United States	8	1.2k	344	257	252	193	12	1.3k
Yohei Misumi Japan	23	1.3k 1.1×	232 0.7×	255 1.0×	388 1.5×	140 0.7×	109	1.5k
Cecília Monteiro United States	10	743 0.6×	138 0.4×	161 0.6×	329 1.3×	103 0.5×	33	968
Manisha Sharma Australia	21	711 0.6×	126 0.4×	338 1.3×	227 0.9×	33 0.2×	30	1.1k
Wan‐Ting Ho United States	18	524 0.5×	76 0.2×	159 0.6×	73 0.3×	144 0.7×	33	856
N Nakamura Japan	11	413 0.4×	410 1.2×	26 0.1×	178 0.7×	112 0.6×	31	945
Lurong Lian United States	17	305 0.3×	112 0.3×	180 0.7×	127 0.5×	111 0.6×	24	753
Candace Strang United States	13	486 0.4×	62 0.2×	101 0.4×	145 0.6×	127 0.7×	17	724
Sadao Kuromitsu Japan	19	500 0.4×	214 0.6×	48 0.2×	76 0.3×	92 0.5×	39	1.1k
J T Potts United States	8	749 0.7×	388 1.1×	80 0.3×	62 0.2×	26 0.1×	12	1.0k
Noga Gadir United States	10	696 0.6×	99 0.3×	88 0.3×	86 0.3×	37 0.2×	18	871

Countries citing papers authored by Jeff Packman

Since Specialization

Citations

This map shows the geographic impact of Jeff Packman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Packman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Packman more than expected).

Fields of papers citing papers by Jeff Packman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Packman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Packman. The network helps show where Jeff Packman may publish in the future.

Co-authorship network of co-authors of Jeff Packman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Packman. A scholar is included among the top collaborators of Jeff Packman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Packman. Jeff Packman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Pignolo, Robert J., Geneviève Baujat, Edward C. Hsiao, et al.. (2020). Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial. Journal of Bone and Mineral Research. 37(10). 1891–1902. 27 indexed citations

Coelho, Teresa, Aaron I. Vinik, Etta J. Vinik, et al.. (2016). Clinical measures in transthyretin familial amyloid polyneuropathy. Muscle & Nerve. 55(3). 323–332. 46 indexed citations

Maurer, Mathew S., Donna R. Grogan, Daniel P. Judge, et al.. (2015). Tafamidis in Transthyretin Amyloid Cardiomyopathy. Circulation Heart Failure. 8(3). 519–526. 98 indexed citations

Vinik, Etta J., Aaron I. Vinik, James F. Paulson, et al.. (2014). Norfolk QOL‐DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy. Journal of the Peripheral Nervous System. 19(2). 104–114. 76 indexed citations

Merlini, Giampaolo, Violaine Planté‐Bordeneuve, Daniel P. Judge, et al.. (2013). Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis. Journal of Cardiovascular Translational Research. 6(6). 1011–1020. 113 indexed citations

Coelho, Teresa, Luı́s F. Maia, Ana Silva, et al.. (2013). Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. Journal of Neurology. 260(11). 2802–2814. 266 indexed citations

Bulawa, Christine, Stephen Connelly, Michael J. DeVit, et al.. (2012). Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proceedings of the National Academy of Sciences. 109(24). 9629–9634. 572 indexed citations breakdown →

Coelho, Teresa, Luı́s F. Maia, Márcia Waddington‐Cruz, et al.. (2012). 138. Tafamidis and nerve fiber function in transthyretin-type familial amyloid polyneuropathy. Clinical Neurophysiology. 123(6). e56–e56. 3 indexed citations

Falk, Rodney H., Matthew Maurer, Savitri Fedson, et al.. (2011). Tafamidis Stabilizes Transthyretin and Improves Clinical Outcomes in Transthyretin Amyloid Cardiomyopathy. Journal of Cardiac Failure. 17(8). S56–S56. 7 indexed citations

10.

Helmke, Stephen, Ayan R. Patel, Frederick L. Ruberg, et al.. (2010). Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin. Circulation Heart Failure. 4(2). 121–128. 72 indexed citations

11.

Appelbaum, Evan, Caitlin Harrigan, Leah H. Biller, et al.. (2009). Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 11(S1). 1 indexed citations

12.

Appelbaum, Evan, Caitlin Harrigan, Warren J. Manning, et al.. (2008). Abstract 694: More Extensive Left Ventricular Hypertrophy in Transthyretin-Type Cardiac Amyloidosis as Compared to Primary Light-Chain Cardiac Amyloidosis. Circulation. 118(suppl_18). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact